 In the latest podcast from our Life Sciences M&A; and competition teams, partners Steven Hacking, Peter Harper, Josh Shapiro, Martin Bechtold, Jeff Bialos, Claire Morgan and Daniel von Brevern explore the topic of foreign direct investment controls which regulate investment into domestic companies - a global trend and a regime which we have seen substantial expansion in throughout the EU, UK and US as well as elsewhere globally. 

Foreign Direct Investment Regimes in the context of M&A deals in the health and life sciences sector

Our Eversheds Sutherland Legal Insights channel has been designed to allow you to listen to our podcasts wherever and whenever it is most convenient. 

We streamline instant access to legal developments which enables you to find specific and relevant insights of interest in one convenient place.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

Management

In our eighth episode we are joined by Ann Fort (US Intellectual Property Partner) and David Wilkinson (UK Company Commercial Partner) for a discussion on Intellectual Property and Anti-Trust. Designed to help you look beyond the headlines and hype cycle, this series will help you make the most of the significant opportunity AI brings on an informed basis, taking into account the rapidly evolving legal, regulatory and risk and control frameworks in which the financial services industry operates.

The Future of Financial Services: Decoding AI - Episode 8: Perspectives on Intellectual Property and Anti-Trust

Utilizing health data requires health and life sciences companies to tread a fine line between innovation and protecting patient privacy. Listen to the latest episode in our Data as an Asset podcast series, where we outline:  key US, EU and UK regulations global health and life sciences companies need to be aware of,   the obstacles and opportunities for research, product development, patients and the public good and  AI's potential for healthcare innovation

Data as an Asset: Utilizing data in the health and life sciences industry

Having first been introduced in the House of Commons 13 months ago, the UK Digital Markets, Competition and Consumers (#DMCC) Act received Royal Assent today. In this podcast, Julia Woodward-Carlton and Annabel Borg explain how the new regime will proceed and what businesses need to do to comply.

UK Digital Markets, Competition and Consumers Bill - Episode 5

 Listen to this podcast highlighting a surge in 2024 mergers and acquisitions in the UK's challenger bank sector, contrasting with 2023's low activity. Paul Pugh, Timothy Fosh, Shelley Evans and Emma Jones discuss the profitability challenges of challenger banks, the complexities of deal structures, regulatory issues, and integration hurdles, suggesting mergers might often be more effective than acquisitions.

Financial Services and M&A Podcast - The UK's challenger banks

In our seventh episode we are joined by Babar Hayat, Head of tech and transformation at Konexo, for a discussion on AI perspectives on digital transformation. Designed to help you look beyond the headlines and hype cycle, this series will help you make the most of the significant opportunity AI brings on an informed basis, taking into account the rapidly evolving legal, regulatory and risk and control frameworks in which the financial services industry operates.  

Foreign Direct Investment Regimes in the context of M&A deals in the health and life sciences sector

Download our free app to listen on your phone